ACCESSION: MSBNK-SMB_Measured-HSA032P0196001
RECORD_TITLE: Characterized; Dolichotheline; LC-ESI-QTOF; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 18
COMMENT: RAW_SPEC {'HC5-pos_1685': {'bp': 18985.0, 'sum': 38586.0}, 'HC4-pos_1616': {'bp': 14227.0, 'sum': 23910.0}, 'HC5-pos_1697': {'bp': 13658.0, 'sum': 25014.0}, 'HC4-pos_1629': {'bp': 8045.0, 'sum': 16845.0}, 'RA20-pos_1680': {'bp': 7027.0, 'sum': 14669.0}, 'RA6-pos_1484': {'bp': 5742.0, 'sum': 10547.0}, 'RA1-pos_1800': {'bp': 3865.0, 'sum': 8342.0}, 'RA3-pos_1617': {'bp': 3380.0, 'sum': 6440.0}, 'HC2-pos_1689': {'bp': 2446.0, 'sum': 6374.0}, 'HC11-pos_1587': {'bp': 1839.0, 'sum': 4578.0}, 'HC17-pos_1521': {'bp': 1709.0, 'sum': 3867.0}, 'HC14-pos_1646': {'bp': 1407.0, 'sum': 3117.0}, 'HC7-pos_1527': {'bp': 1246.0, 'sum': 3226.0}, 'HC22-pos_1505': {'bp': 1045.0, 'sum': 2878.0}, 'QC3-pos_1556': {'bp': 1032.0, 'sum': 2306.0}, 'QC4-pos_1561': {'bp': 858.0, 'sum': 1673.0}, 'QC7-pos_1492': {'bp': 497.0, 'sum': 1006.0}, 'QC8-pos_1498': {'bp': 456.0, 'sum': 915.0}}
COMMENT: RETENTION_TIME_STDEV 0.007
COMMENT: PRECURSOR_M/Z_RAW 196.143405
COMMENT: PRECURSOR_M/Z_STDEV 0.000680
COMMENT: PRECURSOR_IN_MS1 mz 196.144012; int 218.423; delta(ppm) 9.397496
COMMENT: PROPOSED_CHARGE_STATE +1; mz 197.146313; int 28.933; cor 0.945
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 11.054; C8H22NO2P; [M+H]+; delta(ppm) -11.053792
COMMENT: PROPOSED_MF SevenGoldenRules 2.588; C10H17N3O; [M+H]+; delta(ppm) -2.587930
COMMENT: PROPOSED_MF MS-FINDER 4.171; C10H17N3O; [M+H]+; delta(ppm) -2.577786
COMMENT: PROPOSED_MF MS-FINDER 2.903; C8H22NO2P; [M+H]+; delta(ppm) -10.998869
COMMENT: PROPOSED_MF SIRIUS5_Sirius 26.967; C10H17N3O; [M+H]+; delta(ppm) -2.577786
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H17N3O; [M+H]+; delta(ppm) -2.577786
COMMENT: PROPOSED_MF SIRIUS6_Sirius 41.136; C10H17N3O; [M+H]+; delta(ppm) -2.577786
COMMENT: PROPOSED_MF SIRIUS6_Sirius 30.455; C8H15N6; [M+H]+; delta(ppm) 4.267523
COMMENT: PROPOSED_MF SIRIUS6_Sirius 27.912; C7H18FN3O2; [M+H]+; delta(ppm) -8.403311
COMMENT: PROPOSED_MF SIRIUS6_Sirius 20.256; C6H20N4OP; [M+H]+; delta(ppm) -4.153675
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.045; C4H18N7P; [M+H]+; delta(ppm) 2.691613
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.477; C12H19O2; [M+H]+; delta(ppm) -9.423002
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H17N3O; [M+H]+; delta(ppm) -2.577786
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 2.000; FRKKJPSPHJQRPI-UHFFFAOYSA-N; C10H17N3O; histamine-C5:0
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.279; IYVCRLBHSDTDKL-UHFFFAOYSA-N; [M+H]+; CC(C)CC(=O)NCCC1=CNC=N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.394; DQSOUMAHQFDBOY-UHFFFAOYSA-N; [M+H]+; O=C(C)C(NC(C)C)CC1=CN=CN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; JHRKPNVDOPKCMX-UHFFFAOYSA-N; [M+H]+; ON=C1C2(C)CN3CN(C2)CC1(C)C3
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; HXIKQPSPGQKVNW-UQGDGPGGSA-M; [M+H]+; CCCCCC\C=C/C=C/CC([O-])=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.383; IYVCRLBHSDTDKL-UHFFFAOYSA-N; [M+H]+; Dolichotheline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.906; DQSOUMAHQFDBOY-UHFFFAOYSA-N; [M+H]+; 4-(1H-imidazol-5-yl)-3-[(propan-2-yl)amino]butan-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.094; JHRKPNVDOPKCMX-UHFFFAOYSA-N; [M+H]+; N-{5,7-dimethyl-1,3-diazatricyclo[3.3.1.1?,?]decan-6-ylidene}hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; IYVCRLBHSDTDKL-UHFFFAOYSA-N; [M+H]+; Dolichotheline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.758; DQSOUMAHQFDBOY-UHFFFAOYSA-N; [M+H]+; 4-(1H-imidazol-5-yl)-3-[(propan-2-yl)amino]butan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.613; JHRKPNVDOPKCMX-UHFFFAOYSA-N; [M+H]+; N-{5,7-dimethyl-1,3-diazatricyclo[3.3.1.1?,?]decan-6-ylidene}hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.670; QDRJZNBKSMAEIE-UHFFFAOYSA-N; [M+H]+; 5-piperidin-4-yl-3-propan-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.654; QHRQWYQHLSLMOO-UHFFFAOYSA-N; [M+H]+; 3-piperidin-3-yl-5-propan-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; GHHQGGXVXZZQRG-UHFFFAOYSA-N; [M+H]+; (1-methylimidazol-2-yl)-(oxan-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.971; FKFLQBWAWUQGOW-BDAKNGLRSA-N; [M+H]+; 2-[(2S,4R)-4-methoxypyrrolidin-2-yl]-4,5-dimethyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.962; LJPFGGDQLGMPPG-UHFFFAOYSA-N; [M+H]+; 3,5-dimethyl-4-(piperazin-1-ylmethyl)-1,2-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.953; OGQYGLMJTYQJDL-UHFFFAOYSA-N; [M+H]+; 2-[(3,5-dimethylpyrazol-1-yl)methyl]morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.945; UDQDKTDFLLQDOP-UHFFFAOYSA-N; [M+H]+; 5-N-(1-methoxypropan-2-yl)-5-N-methylpyridine-2,5-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.913; CCROGNJNLALLND-UHFFFAOYSA-N; [M+H]+; 4-[[2-methoxyethyl(methyl)amino]methyl]pyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.885; FOQMUVRIBLMRNQ-UHFFFAOYSA-N; [M+H]+; 4-[2-(dimethylamino)ethoxy]benzene-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.875; PBLVKHOPIXEGJM-UHFFFAOYSA-N; [M+H]+; 2-[piperidin-4-yl(prop-2-ynyl)amino]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.826; YHWLQRJYWUMHEZ-WCBMZHEXSA-N; [M+H]+; [(2R,3S)-2-(2-methylpyrazol-3-yl)oxan-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.821; RSTXDYWIDMAHHE-UHFFFAOYSA-N; [M+H]+; (2-methylpyrazol-3-yl)-piperidin-4-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.815; PCPCCARECSKSKY-UHFFFAOYSA-N; [M+H]+; N-methyl-N-[(5-methyl-1,3-oxazol-4-yl)methyl]pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.815; BJMLIKMTFQKDFH-UHFFFAOYSA-N; [M+H]+; (1-methylimidazol-2-yl)-piperidin-4-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.813; PACPCAVBQIGQPX-UHFFFAOYSA-N; [M+H]+; 2-(5-piperidin-4-ylpyrazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.801; RQHLIISYGVVOMZ-UHFFFAOYSA-N; [M+H]+; 5-piperidin-3-yl-3-propan-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.799; IWRQPAYJOAVNLV-UWVGGRQHSA-N; [M+H]+; 4-[(3R,4S)-4-(methoxymethyl)pyrrolidin-3-yl]-1-methylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.777; UEQYVPMKGQPTFU-ZJUUUORDSA-N; [M+H]+; (2S,3R)-2-(1-propan-2-ylpyrazol-4-yl)oxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.777; JOFRKRVKFQLQIU-UHFFFAOYSA-N; [M+H]+; 2-(2-propan-2-ylpyrazol-3-yl)oxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.755; COPZBDLYLMQFFO-UHFFFAOYSA-N; [M+H]+; 3-(1,3,5-trimethylpyrazol-4-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.753; GJJDFSWVMGWFQG-UHFFFAOYSA-N; [M+H]+; 3-(1,4-diazepan-1-ylmethyl)-5-methyl-1,2-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.748; IVACNLAJPODRBE-UHFFFAOYSA-N; [M+H]+; 1-(2-cyanoethyl)-1-cyclohexylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.735; GJKMWFATYMRFHV-UHFFFAOYSA-N; [M+H]+; 4-morpholin-4-ylpiperidine-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.734; ISJJUXPLURIOKP-UHFFFAOYSA-N; [M+H]+; 4-(diethylaminomethyl)-2-methyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.723; LVYOEHNEFWUEDT-UHFFFAOYSA-N; [M+H]+; N,N-diethyl-4-methoxy-6-methylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.718; OQOIWCFPTAPKHF-UHFFFAOYSA-N; [M+H]+; 2-(2,6-dimethylpyrimidin-4-yl)oxy-N,N-dimethylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.706; JLYGWGZFPGZJOT-UHFFFAOYSA-N; [M+H]+; 1-(2-methoxyethyl)-4,5,6,7-tetrahydroindazol-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.701; KEFKNRXOLRNLKI-UHFFFAOYSA-N; [M+H]+; 4-amino-2-methyl-5-pentyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.662; NTPFBFYOCKHFML-UHFFFAOYSA-N; [M+H]+; 1-(5-propan-2-yl-1,2,4-oxadiazol-3-yl)cyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.629; CVJLMJVOWKPEKF-UHFFFAOYSA-N; [M+H]+; 2-(2-piperidin-1-ylpropyl)-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.629; UJUDXPWUKWMYKV-UHFFFAOYSA-N; [M+H]+; 2-(1-piperidin-1-ylpropyl)-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.615; GQDAZIGPMICNKK-YUMQZZPRSA-N; [M+H]+; 2-ethyl-5-[(2S,3S)-2-methylpiperidin-3-yl]-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.608; DXUJGHOMRZXSAQ-UHFFFAOYSA-N; [M+H]+; 4-(3-ethyl-1,2,4-oxadiazol-5-yl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.495; YXMDUGUKTNNVFQ-UHFFFAOYSA-N; [M+H]+; 2-piperazin-1-yl-N-prop-2-ynylpropanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -112.141; IYVCRLBHSDTDKL; [M+H]+; Dolichotheline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -119.879; DQSOUMAHQFDBOY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -213.695; BJMLIKMTFQKDFH; [M+H]+; Ambcb4005918
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -262.441; JYAWAWILSOXYDB; [M+H]+; Oprea1_082147
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.592; KEFKNRXOLRNLKI; [M+H]+; 6-Amino-2-methyl-5-pentyl-4-pyrimidinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -299.612; BHDKFMDJCREHTJ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -318.586; CVJLMJVOWKPEKF; [M+H]+; 2-(2-piperidin-1-ylpropyl)-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -322.324; KKSFQDNAYJWTCZ; [M+H]+; 2,6-diamino-4-(diethylamino)phenol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -358.604; UJUDXPWUKWMYKV; [M+H]+; 2-(1-Piperidino-1-propyl)-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -360.954; IVACNLAJPODRBE; [M+H]+; 1-(2-cyanoethyl)-1-cyclohexylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -385.685; JHRKPNVDOPKCMX; [M+H]+; Oprea1_156679
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.402; IYVCRLBHSDTDKL; [M+H]+; Dolichotheline
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -74.702; IYVCRLBHSDTDKL; [M+H]+; N-[2-(1H-imidazol-4-yl)ethyl]-3-methylbutanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -231.821; MGXXZRRADAQHMW; [M+H]+; N-[(1-tert-butyl-3,5-dimethylpyrazol-4-yl)methylidene]hydroxylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -233.467; ZDAUOJUKQPYKAC; [M+H]+; 3-methyl-N-(2-methylbutan-2-yl)-1H-pyrazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -246.044; CQQPSLDLWYXHKP; [M+H]+; N-(2-methylpentan-2-yl)-1H-pyrazole-3-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -266.208; QJNJGKBWSONYNM; [M+H]+; N-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]propan-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -283.394; PACPCAVBQIGQPX; [M+H]+; 2-[5-(piperidin-4-yl)-1H-pyrazol-1-yl]ethan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -288.085; JYAWAWILSOXYDB; [M+H]+; 2-Amino-6-methyl-5-(3-methylbutyl)pyrimidin-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -288.493; DQSOUMAHQFDBOY; [M+H]+; 4-(1H-imidazol-5-yl)-3-[(propan-2-yl)amino]butan-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -290.484; BHDKFMDJCREHTJ; [M+H]+; N-cycloheptyl-5-methyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -308.857; GHHQGGXVXZZQRG; [M+H]+; (R)-(1-methylimidazol-2-yl)-(oxan-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.888; IYVCRLBHSDTDKL; [M+H]+; N-[2-(1H-imidazol-4-yl)ethyl]-3-methylbutanamide
COMMENT: CONFIDENCE Level 3: Tentative candidate, Dolichotheline, IYVCRLBHSDTDKL-UHFFFAOYSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1);
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C10H17N3O
CH$EXACT_MASS: 195.137162
CH$SMILES: CC(C)CC(=O)NCCC1=CN=CN1
CH$IUPAC: InChI=1S/C10H17N3O/c1-8(2)5-10(14)12-4-3-9-6-11-7-13-9/h6-8H,3-5H2,1-2H3,(H,11,13)(H,12,14)
CH$LINK: CHEBI CHEBI:80664
CH$NAME: Dolichotheline
CH$NAME: Dolichotheline
CH$NAME: N-[2-(1H-imidazol-5-yl)ethyl]-3-methylbutanamide
CH$LINK: INCHIKEY IYVCRLBHSDTDKL-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:168082
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 µm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 2.454
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 196.143933
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0002-9100000000-5b2593e0dedaaada5156
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  41.0386381 36.8875 41.038951 26.3898 21.84 0.8533 14 f{C3H5}/1.50ppm,p-C7H13N3O1
  57.0702637 132.0691 57.070507 18.4159 54.97 0.9099 17 f{C4H9}/6.78ppm,p-C6H9N3O1
  68.0502199 95.1947 68.050363 19.6913 38.68 1.0000 16 f{C4H6N1}/10.94ppm,p-C6H12N2O1
  70.0654336 47.0699 70.065584 15.5141 36.70 -0.0694 14 f{C4H8N1}/4.40ppm,p-C6H10N2O1
  83.0611483 68.8761 83.061351 17.1801 25.79 0.9352 18 f{C4H7N2}/9.31ppm,p-C6H11N1O1
  84.0810894 75.9389 84.081296 21.3722 63.33 0.4903 13 f{C5H10N1}/3.73ppm,p-C5H8N2O1
  95.0607026 999.0000 95.060960 13.6544 0.00 0.9697 18 f{C5H7N2}/3.45ppm,p-C5H11N1O1
  112.0877076 277.0470 112.088054 14.9258 97.49 0.9119 18 f{C7H12O1}/-4.99ppm,p-C3H6N3
PK$NUM_PEAK: 8
PK$PEAK: m/z int. rel.int.
  41.038638 36.89 36
  57.070264 132.07 132
  68.050220 95.19 95
  70.065434 47.07 47
  83.061148 68.88 68
  84.081089 75.94 75
  95.060703 999.00 999
  112.087708 277.05 277
//
